340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Obama Administration Takes Some of the Bite out of Medicare Part D Clawbacks

The $4.3 billion reduction is expected to ease financial pressure on states. But whether that works to 340B participants' benefit remains to be seen.
 

Print Article

Image of a metal claw.March 11, 2010 – The Obama administration has sliced $4.3 billion off the $17.5 billion that states owe the federal government for the costs Washington incurred when it took responsibility for the prescription drug expenses of state residents dually eligible for Medicare and Medicaid.

The move, announced in late February by U.S. Health and Human Services Secretary Kathleen Sebelius, is expected to relieve some of the financial pressure on states reeling from the economic recession. Among other belt-tightening steps, California and other states have put the squeeze on 340B covered entities. California lawmakers, for example, barred 340B covered entities from using the 340B Medicaid carve-out and required covered entities to bill Medi-Cal, the state Medicaid program, for drugs at actual acquisition cost.  It remains to be seen whether the Golden State and others will use their Medicare Part D clawback windfalls from Washington to ease such pressures on 340B providers.March 11, 2010 – The Obama administration has sliced $4.3 billion off the $17.5 billion that states owe the federal government for the costs Washington incurred when it took responsibility for the prescription drug expenses of state residents dually eligible for Medicare and Medicaid.

The so-called clawback payments that the states owe the federal government were implemented with the passage of the Medicare Prescription Drug Improvement and Modernization Act of 2003 (MMA), when Medicaid enrollees who are also eligible for Medicare were shifted from the Medicaid program to the Medicare Part D program for their drugs. To offset the added expense to the federal government of the costs of the dual eligibles’ drugs, the MMA set up a schedule of monthly payments for states to make to the federal government.
Some states argued that the amounts sought were so overinflated that they would have been better off continuing to pay for the dual eligible’s drugs. Others sought relief from the courts. In 2006, however, the U.S. Supreme Court declined to hear a lawsuit brought by several states challenging the clawbacks as an unconstitutional federal tax on the states.

The money for the clawback relief comes from the American Recovery and Reinvestment Act of 2009 (ARRA), which temporarily raised the Federal Medical Assistance Percentage (FMAP) payments that states get from the federal government to help pay for their Medicaid programs from an average of 57 percent of Medicaid costs to an average of 65 percent. The increases covered fiscal years 2009 and 2010 and the first quarter of fiscal 2011. President Obama’s fiscal 2011 budget request would extend the increases through June 2011, as would an “extender” bill being considered by Congress.

In a Feb. 18 call with state governors, Secretary Sebelius announced that the administration had decided to use the FMAP enhancements to reduce the states’ clawback obligations, as requested by the National Association of Medicaid Directors.

“We believe today’s action will help states as they struggle to maintain Medicaid and other budget priorities in these difficult economic times,” Sebelius said.  “This relief will help the states continue to provide critical health care services for the nearly 60 million beneficiaries who depend on it.”

Under the new administration policy, clawback credits will be calculated retroactively for the entire period of the FMAP increase and then applied to future payments beginning this month.

Some of the states that will get the most relief include California ($675.4 million), New York ($407.8 million), Florida ($282.6 million), Pennsylvania ($228.9 million) Texas ($210.0 million) and Illinois ($199.7 million). Click here to see how much your state will receive.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
16 Feb

There’s a reason why you may have been hearing some controversial things about #340B lately. These misinformation campaigns go way back and have trails leading to Big Pharma. Learn why pharma-funded groups are invested in derailing a federal program that doesn’t cost the…

Reply on Twitter 1890990490486726953 Retweet on Twitter 1890990490486726953 1 Like on Twitter 1890990490486726953 3 Twitter 1890990490486726953
340bhealth 340B Health @340bhealth ·
15 Feb

It would cost just one safety-net hospital $24 million more each year to pay full price for two @JNJNews drugs upfront and wait for drugmaker rebates that might never come.

Then consider the crippling financial harm that would occur if you were to expand those costs to purchase…

Reply on Twitter 1890756196560482421 Retweet on Twitter 1890756196560482421 1 Like on Twitter 1890756196560482421 1 Twitter 1890756196560482421
340bhealth 340B Health @340bhealth ·
14 Feb

Show the team of experts here at #340B Health some love this Valentine’s Day by streaming our “listener mailbag” episode of #340BInsight: http://bit.ly/3YWHlJ4. Then learn more in just over a week at the @340BCoalition Winter Conference in San Diego!

Reply on Twitter 1890392047640527294 Retweet on Twitter 1890392047640527294 Like on Twitter 1890392047640527294 Twitter 1890392047640527294
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health